These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7709404

  • 1. Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
    Cocozza M, Picano T, Oliviero U, Russo N, Coto V, Milani M.
    Stroke; 1995 Apr; 26(4):597-601. PubMed ID: 7709404
    [Abstract] [Full Text] [Related]

  • 2. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M, Milani M, Picano T, Oliviero U, Russo N, Coto V.
    Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
    Giustina A, Perini P, Desenzani P, Bossoni S, Ianniello P, Milani M, Davì G, Romanelli G.
    Diabetes; 1998 Mar; 47(3):423-30. PubMed ID: 9519749
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and efficacy of picotamide, a dual-action antithromboxane agent, in diabetic patients with carotid atherosclerosis: a 6-year follow-up study.
    Coto V, Oliviero U, Cocozza M, Milani M.
    J Int Med Res; 1998 Mar; 26(4):200-5. PubMed ID: 9818786
    [Abstract] [Full Text] [Related]

  • 5. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
    Milani M, Longoni A, Maderna M.
    Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
    [Abstract] [Full Text] [Related]

  • 6. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
    Vetrano A, Milani M, Corsini G.
    G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219
    [Abstract] [Full Text] [Related]

  • 7. Effect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study. The ADEP Group.
    Balsano F, Violi F.
    Circulation; 1993 May; 87(5):1563-9. PubMed ID: 8491012
    [Abstract] [Full Text] [Related]

  • 8. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A, Violi F.
    Vasc Health Risk Manag; 2007 May; 3(1):93-8. PubMed ID: 17583179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
    Pibiri L, Petruzzo P, De Giudici A, Brotzu G.
    Clin Ter; 1990 May 31; 133(4):233-7. PubMed ID: 2142911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG, Coccheri S, Marubini E, Violi F, Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group.
    Eur Heart J; 2004 Oct 31; 25(20):1845-52. PubMed ID: 15474700
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M, Molaschi M, Ponzetto M, Macchione C, Poli L, Bonino F, Fabris F.
    Angiology; 1994 Feb 31; 45(2):137-41. PubMed ID: 8129189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB.
    Circulation; 2005 May 03; 111(17):2233-40. PubMed ID: 15851601
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.